MPWT
VYGR icon

MassMutual Private Wealth & Trust’s Voyager Therapeutics VYGR Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-244
Closed -$3K – 950
2020
Q3 		$3K Buy
+244
New +$2.86K ﹤0.01% 679

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MassMutual Private Wealth & Trust's VYGR Position: Q4 2020 in Review

MassMutual Private Wealth & Trust sold out of Voyager Therapeutics (VYGR) in Q4 2020, closing a stake of 244 shares — an estimated $3K sold.

MassMutual Private Wealth & Trust first reported a position in VYGR in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 101 funds tracked by Wall St. Rank hold VYGR as of Q4 2020.

  • MassMutual Private Wealth & Trust reported no remaining Voyager Therapeutics position as of Q4 2020 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 244 Voyager Therapeutics shares in Q4 2020, an estimated $3K.
  • MassMutual Private Wealth & Trust first reported a position in Voyager Therapeutics in Q3 2020 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Voyager Therapeutics position peaked at $3K in Q3 2020.
  • 101 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2020.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2020, filed 16 Feb 2021.